Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status
N/A
This is a worldwide, multicenter, non-interventional, retrospective study o...
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)
N/A
To estimate the prevalence of EGFR mutation in a representative sample of p...
Status
Completed
Location
Research Site
Start Date
2010-03
Trial ID
NCT01081496
Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery
PHASE2
Doctors leading this study would like to learn about providing cancer treat...
Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy
PHASE2
The aim of the present study is to evaluate the efficacy and safety of palb...